The APP intracellular domain (AICD) inhibits Wnt signalling and promotes neurite outgrowth

Biochimica et Biophysica Acta - Molecular Cell Research

Volumn 1823, Issue 8, 2012, Pages 1233-1241

  Zhou, Fangfang ^a,b   Gong, Kai ^a   Song, Bo ^a   Ma, Tuo ^a   van Laar, Theo ^b   Gong, Yandao ^a   Zhang, Long ^b  

^a TSINGHUA UNIVERSITY   (China)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

APP intracellular domain (AICD); Neurite outgrowth; Wnt signalling

Indexed keywords

AMYLOID PRECURSOR PROTEIN; AXIN; BETA CATENIN; GLYCOGEN SYNTHASE KINASE 3BETA; MYC PROTEIN; NICASTRIN; WNT PROTEIN;

ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CELL PROLIFERATION; COMPLEX FORMATION; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; GENE EXPRESSION REGULATION; GROWTH DISORDER; HUMAN; HUMAN CELL; MOUSE; NERVE CELL; NERVE FIBER GROWTH; NEUROBLASTOMA CELL; NONHUMAN; PHEOCHROMOCYTOMA CELL; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; SIGNAL TRANSDUCTION; TRANSCRIPTION INITIATION; TRANSCRIPTION REGULATION; UBIQUITINATION;

AMYLOID BETA-PROTEIN PRECURSOR; AMYLOID PRECURSOR PROTEIN SECRETASES; ANIMALS; CELL PROLIFERATION; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENES, REPORTER; GLYCOGEN SYNTHASE KINASE 3; HEK293 CELLS; HUMANS; LUCIFERASES, RENILLA; MEMBRANE GLYCOPROTEINS; MICE; NERVE GROWTH FACTOR; NEURITES; NEURONS; PRIMARY CELL CULTURE; PROTEIN STRUCTURE, TERTIARY; PROTO-ONCOGENE PROTEINS C-MYC; WNT SIGNALING PATHWAY;

RATTUS;

EID: 84862158901     PISSN: 01674889     EISSN: 18792596     Source Type: Journal    
DOI: 10.1016/j.bbamcr.2012.05.011     Document Type: Article

References (61)

1. Logan C.Y., Nusse R. The Wnt signaling pathway in development and disease. Annu. Rev. Cell Dev. Biol. 2004, 20:781-810.
2. Reya T., Clevers H. Wnt signalling in stem cells and cancer. Nature 2005, 434:843-850.
3. Moon R.T., Kohn A.D., De Ferrari G.V., Kaykas A. WNT and beta-catenin signalling: diseases and therapies. Nat. Rev. Genet. 2004, 5:691-701.
4. MacDonald B.T., Tamai K., He X. Wnt/beta-catenin signaling: components, mechanisms, and diseases. Dev. Cell 2009, 17:9-26.
5. Liu C., Li Y., Semenov M., Han C., Baeg G.H., Tan Y., Zhang Z., Lin X., He X. Control of beta-catenin phosphorylation/degradation by a dual-kinase mechanism. Cell 2002, 108:837-847.
6. Nelson W.J., Nusse R. Convergence of Wnt, beta-catenin, and cadherin pathways. Science 2004, 303:1483-1487.
7. Yardy G.W., Brewster S.F. Wnt signalling and prostate cancer. Prostate Cancer Prostatic Dis. 2005, 8:119-126.
8. Clevers H. Wnt/beta-catenin signaling in development and disease. Cell 2006, 127:469-480.
9. Ching W., Nusse R. A dedicated Wnt secretion factor. Cell 2006, 125:432-433.
10. Zeng X., Tamai K., Doble B., Li S., Huang H., Habas R., Okamura H., Woodgett J., He X. A dual-kinase mechanism for Wnt co-receptor phosphorylation and activation. Nature 2005, 438:873-877.
11. Bilic J., Huang Y.L., Davidson G., Zimmermann T., Cruciat C.M., Bienz M., Niehrs C. Wnt induces LRP6 signalosomes and promotes dishevelled-dependent LRP6 phosphorylation. Science 2007, 316:1619-1622.
12. Taelman V.F., Dobrowolski R., Plouhinec J.L., Fuentealba L.C., Vorwald P.P., Gumper I., Sabatini D.D., De Robertis E.M. Wnt signaling requires sequestration of glycogen synthase kinase 3 inside multivesicular endosomes. Cell 2010, 143:1136-1148.
13. Niehrs C., Acebron S.P. Wnt signaling: multivesicular bodies hold GSK3 captive. Cell 2010, 143:1044-1046.
14. Kang J., Lemaire H.G., Unterbeck A., Salbaum J.M., Masters C.L., Grzeschik K.H., Multhaup G., Beyreuther K., Muller-Hill B. The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor. Nature 1987, 325:733-736.
15. Suh Y.H., Checler F. Amyloid precursor protein, presenilins, and alpha-synuclein: molecular pathogenesis and pharmacological applications in Alzheimer's disease. Pharmacol. Rev. 2002, 54:469-525.
16. Esler W.P., Wolfe M.S. A portrait of Alzheimer secretases-new features and familiar faces. Science 2001, 293:1449-1454.
17. Borg J.P., Ooi J., Levy E., Margolis B. The phosphotyrosine interaction domains of X11 and FE65 bind to distinct sites on the YENPTY motif of amyloid precursor protein. Mol. Cell. Biol. 1996, 16:6229-6241.
18. Fiore F., Zambrano N., Minopoli G., Donini V., Duilio A., Russo T. The regions of the Fe65 protein homologous to the phosphotyrosine interaction/phosphotyrosine binding domain of Shc bind the intracellular domain of the Alzheimer's amyloid precursor protein. J. Biol. Chem. 1995, 270:30853-30856.
19. Watanabe T., Sukegawa J., Sukegawa I., Tomita S., Iijima K., Oguchi S., Suzuki T., Nairn A.C., Greengard P. A 127-kDa protein (UV-DDB) binds to the cytoplasmic domain of the Alzheimer's amyloid precursor protein. J. Neurochem. 1999, 72:549-556.
20. Zambrano N., Buxbaum J.D., Minopoli G., Fiore F., De Candia P., De Renzis S., Faraonio R., Sabo S., Cheetham J., Sudol M., Russo T. Interaction of the phosphotyrosine interaction/phosphotyrosine binding-related domains of Fe65 with wild-type and mutant Alzheimer's beta-amyloid precursor proteins. J. Biol. Chem. 1997, 272:6399-6405.
21. Chow N., Korenberg J.R., Chen X.N., Neve R.L. APP-BP1, a novel protein that binds to the carboxyl-terminal region of the amyloid precursor protein. J. Biol. Chem. 1996, 271:11339-11346.
22. Scheinfeld M.H., Roncarati R., Vito P., Lopez P.A., Abdallah M., D'Adamio L. Jun NH2-terminal kinase (JNK) interacting protein 1 (JIP1) binds the cytoplasmic domain of the Alzheimer's beta-amyloid precursor protein (APP). J. Biol. Chem. 2002, 277:3767-3775.
23. Pastorino L., Sun A., Lu P.J., Zhou X.Z., Balastik M., Finn G., Wulf G., Lim J., Li S.H., Li X., Xia W., Nicholson L.K., Lu K.P. The prolyl isomerase Pin1 regulates amyloid precursor protein processing and amyloid-beta production. Nature 2006, 440:528-534.
24. Cao X., Sudhof T.C. A transcriptionally [correction of transcriptively] active complex of APP with Fe65 and histone acetyltransferase Tip60. Science 2001, 293:115-120.
25. Ozaki T., Li Y., Kikuchi H., Tomita T., Iwatsubo T., Nakagawara A. The intracellular domain of the amyloid precursor protein (AICD) enhances the p53-mediated apoptosis. Biochem. Biophys. Res. Commun. 2006, 351:57-63.
26. Alves da Costa C., Sunyach C., Pardossi-Piquard R., Sevalle J., Vincent B., Boyer N., Kawarai T., Girardot N., St George-Hyslop P., Checler F. Presenilin-dependent gamma-secretase-mediated control of p53-associated cell death in Alzheimer's disease. J. Neurosci. 2006, 26:6377-6385.
27. Checler F., Sunyach C., Pardossi-Piquard R., Sevalle J., Vincent B., Kawarai T., Girardot N., St George-Hyslop P., da Costa C.A. The gamma/epsilon-secretase-derived APP intracellular domain fragments regulate p53. Curr. Alzheimer Res. 2007, 4:423-426.
28. Checler F., Dunys J., Pardossi-Piquard R., da Costa C.A. p53 is regulated by and regulates members of the gamma-secretase complex. Neurodegener. Dis. 2010, 7:50-55.
29. Zhang Y.W., Wang R., Liu Q., Zhang H., Liao F.F., Xu H. Presenilin/gamma-secretase-dependent processing of beta-amyloid precursor protein regulates EGF receptor expression. Proc. Natl. Acad. Sci. U. S. A. 2007, 104:10613-10618.
30. Zhou F., Gong K., Laar T.V., Gong Y., Zhang L. Wnt/beta-catenin signal pathway stabilizes APP intracellular domain (AICD) and promotes its transcriptional activity. Biochem. Biophys. Res. Commun. 2011, 412:68-73.
31. Zhang L., Gao X., Wen J., Ning Y., Chen Y.G. Dapper 1 antagonizes Wnt signaling by promoting dishevelled degradation. J. Biol. Chem. 2006, 281:8607-8612.
32. Huang W., Chang H.Y., Fei T., Wu H., Chen Y.G. GSK3 beta mediates suppression of cyclin D2 expression by tumor suppressor PTEN. Oncogene 2007, 26:2471-2482.
33. Schroeter E.H., Kisslinger J.A., Kopan R. Notch-1 signalling requires ligand-induced proteolytic release of intracellular domain. Nature 1998, 393:382-386.
34. Zhang L., Zhou F., van Laar T., Zhang J., van Dam H., Ten Dijke P. Fas-associated factor 1 antagonizes Wnt signaling by promoting {beta}-catenin degradation. Mol. Biol. Cell 2011, 22:1617-1624.
35. Zhou F., Zhang L., Wang A., Song B., Gong K., Hu M., Zhang X., Zhao N., Gong Y. The association of GSK3 beta with E2F1 facilitates nerve growth factor-induced neural cell differentiation. J. Biol. Chem. 2008, 283:14506-14515.
36. Zhou F., Zhang L., van Laar T., van Dam H., Ten Dijke P. GSK3{beta} inactivation induces apoptosis of leukemia cells by repressing the function of c-Myb. Mol. Biol. Cell. 2011, 22:3533-3540.
37. Zhou F., Zhang L., Gong K., Lu G., Sheng B., Wang A., Zhao N., Zhang X., Gong Y. LEF-1 activates the transcription of E2F1. Biochem. Biophys. Res. Commun. 2008, 365:149-153.
38. Buxbaum J.D., Gandy S.E., Cicchetti P., Ehrlich M.E., Czernik A.J., Fracasso R.P., Ramabhadran T.V., Unterbeck A.J., Greengard P. Processing of Alzheimer beta/A4 amyloid precursor protein: modulation by agents that regulate protein phosphorylation. Proc. Natl. Acad. Sci. U. S. A. 1990, 87:6003-6006.
39. Zhou F., van Laar T., Huang H., Zhang L. APP and APLP1 are degraded through autophagy in response to proteasome inhibition in neuronal cells. Protein Cell 2011, 2:377-383.
40. Zhang L., Zhou H., Su Y., Sun Z., Zhang H., Zhang Y., Ning Y., Chen Y.G., Meng A. Zebrafish Dpr2 inhibits mesoderm induction by promoting degradation of nodal receptors. Science 2004, 306:114-117.
41. Price D.L., Sisodia S.S. Mutant genes in familial Alzheimer's disease and transgenic models. Annu. Rev. Neurosci. 1998, 21:479-505.
42. Korinek V., Barker N., Morin P.J., van Wichen D., de Weger R., Kinzler K.W., Vogelstein B., Clevers H. Constitutive transcriptional activation by a beta-catenin-Tcf complex in APC-/- colon carcinoma. Science 1997, 275:1784-1787.
43. Hsu S.C., Galceran J., Grosschedl R. Modulation of transcriptional regulation by LEF-1 in response to Wnt-1 signaling and association with beta-catenin. Mol. Cell. Biol. 1998, 18:4807-4818.
44. Li T., Ma G., Cai H., Price D.L., Wong P.C. Nicastrin is required for assembly of presenilin/gamma-secretase complexes to mediate Notch signaling and for processing and trafficking of beta-amyloid precursor protein in mammals. J. Neurosci. 2003, 23:3272-3277.
45. Morin P.J., Sparks A.B., Korinek V., Barker N., Clevers H., Vogelstein B., Kinzler K.W. Activation of beta-catenin-Tcf signaling in colon cancer by mutations in beta-catenin or APC. Science 1997, 275:1787-1790.
46. Dajani R., Fraser E., Roe S.M., Yeo M., Good V.M., Thompson V., Dale T.C., Pearl L.H. Structural basis for recruitment of glycogen synthase kinase 3beta to the axin-APC scaffold complex. EMBO J. 2003, 22:494-501.
47. Shum A.S., Poon L.L., Tang W.W., Koide T., Chan B.W., Leung Y.C., Shiroishi T., Copp A.J. Retinoic acid induces down-regulation of Wnt-3a, apoptosis and diversion of tail bud cells to a neural fate in the mouse embryo. Mech. Dev. 1999, 84:17-30.
48. Shackleford G.M., Willert K., Wang J., Varmus H.E. The Wnt-1 proto-oncogene induces changes in morphology, gene expression, and growth factor responsiveness in PC12 cells. Neuron 1993, 11:865-875.
49. Baek S.H., Ohgi K.A., Rose D.W., Koo E.H., Glass C.K., Rosenfeld M.G. Exchange of N-CoR corepressor and Tip60 coactivator complexes links gene expression by NF-kappaB and beta-amyloid precursor protein. Cell 2002, 110:55-67.
50. Kim H.S., Kim E.M., Lee J.P., Park C.H., Kim S., Seo J.H., Chang K.A., Yu E., Jeong S.J., Chong Y.H., Suh Y.H. C-terminal fragments of amyloid precursor protein exert neurotoxicity by inducing glycogen synthase kinase-3beta expression. FASEB J. 2003, 17:1951-1953.
51. Hebert S.S., Serneels L., Tolia A., Craessaerts K., Derks C., Filippov M.A., Muller U., De Strooper B. Regulated intramembrane proteolysis of amyloid precursor protein and regulation of expression of putative target genes. EMBO Rep. 2006, 7:739-745.
52. Ryan K.A., Pimplikar S.W. Activation of GSK-3 and phosphorylation of CRMP2 in transgenic mice expressing APP intracellular domain. J. Cell Biol. 2005, 171:327-335.
53. Sanchez S., Sayas C.L., Lim F., Diaz-Nido J., Avila J., Wandosell F. The inhibition of phosphatidylinositol-3-kinase induces neurite retraction and activates GSK3. J. Neurochem. 2001, 78:468-481.
54. Chou A.H., Howard B.D. Inhibition by Wnt-1 or Wnt-3a of nerve growth factor-induced differentiation of PC12 cells is reversed by bisindolylmaleimide-I but not by several other PKC inhibitors. Oncogene 2002, 21:6348-6355.
55. Muller T., Concannon C.G., Ward M.W., Walsh C.M., Tirniceriu A.L., Tribl F., Kogel D., Prehn J.H., Egensperger R. Modulation of gene expression and cytoskeletal dynamics by the amyloid precursor protein intracellular domain (AICD). Mol. Biol. Cell 2007, 18:201-210.
56. Perez R.G., Zheng H., Van der Ploeg L.H., Koo E.H. The beta-amyloid precursor protein of Alzheimer's disease enhances neuron viability and modulates neuronal polarity. J. Neurosci. 1997, 17:9407-9414.
57. Zheng H., Jiang M., Trumbauer M.E., Sirinathsinghji D.J., Hopkins R., Smith D.W., Heavens R.P., Dawson G.R., Boyce S., Conner M.W., Stevens K.A., Slunt H.H., Sisoda S.S., Chen H.Y., Van der Ploeg L.H. beta-Amyloid precursor protein-deficient mice show reactive gliosis and decreased locomotor activity. Cell 1995, 81:525-531.
58. Chang K.A., Kim H.S., Ha T.Y., Ha J.W., Shin K.Y., Jeong Y.H., Lee J.P., Park C.H., Kim S., Baik T.K., Suh Y.H. Phosphorylation of amyloid precursor protein (APP) at Thr668 regulates the nuclear translocation of the APP intracellular domain and induces neurodegeneration. Mol. Cell. Biol. 2006, 26:4327-4338.
59. Kimberly W.T., Zheng J.B., Guenette S.Y., Selkoe D.J. The intracellular domain of the beta-amyloid precursor protein is stabilized by Fe65 and translocates to the nucleus in a notch-like manner. J. Biol. Chem. 2001, 276:40288-40292.
60. Kang D.E., Soriano S., Xia X., Eberhart C.G., De Strooper B., Zheng H., Koo E.H. Presenilin couples the paired phosphorylation of beta-catenin independent of axin: implications for beta-catenin activation in tumorigenesis. Cell 2002, 110:751-762.
61. Xia X., Qian S., Soriano S., Wu Y., Fletcher A.M., Wang X.J., Koo E.H., Wu X., Zheng H. Loss of presenilin 1 is associated with enhanced beta-catenin signaling and skin tumorigenesis. Proc. Natl. Acad. Sci. U. S. A. 2001, 98:10863-10868.